Medicine
STAT+: Ultragenyx cuts staff after another study fails
Ultragenyx announced that it's laying off about 20% of its staff as it ends development of two rare disease drugs.
STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more
The Trump administration will survey key components of pharmaceutical production in order to identify domestic supply chain vulnerabilities.
STAT+: Sens. Wyden and Sanders, backers of Medicare for All, set to take charge of key committees
The Democratic flip of the Senate is expected to put two Democrats who support Medicare for All in charge of key committees.
STAT+: The biotech startups skipping AI for drug discovery
In this edition of AI Prognosis: These biotech startups don't think drug discovery is where AI can make the biggest difference.
STAT+: Former Madrigal Pharmaceuticals executive alleges coverup of safety issues tied to its drug
A top former executive at Madrigal Pharmaceuticals has filed a lawsuit in federal court alleging a coverup of drug safety issues.
Top health takeaways from the midterm elections
Democrats gained control of both chambers of Congress, and doctors and scientists won key seats. Here are the top health takeaways from the midterms.
‘Every family has silences’: Kathryn Hunter on despair, desire, dislodgeable limbs – and her acting genius
She has played King Lear, all three witches in Macbeth and an ape turned variety performer in Kafka’s Monkey. As she prepares for a new show, she discusses the soaring highs and d…
Opinion: I moved to Europe for free health care. I miss my patient portal
“To be honest, in Malta, I pay for medical care all the time. I just pay differently,” writes Mariska Breland.
A moment that changed me: I was terrified of my own body – until a surprising 20-mile bike ride
I grew up with spinal conditions that solidified my sense of being ‘weak and weird’. By my late 30s, I was feeling burnt out. But an invitation from a colleague set me on an unexp…
Why pharma firms are going to Earth’s orbit in search of new cancer drugs
A space capsule 300 miles above us is growing the tiny crystals of a potential cancer drug in microgravityRoughly 300 miles above our heads, three washing machine-sized capsules a…
The next global pandemic could be brewing on a mink farm in Utah – and little is being done to stop it | George Monbiot
Mink farms are the perfect petri dishes for deadly flu strains to emerge. Yet officials appear to be protecting business interests over human livesCould this be ground zero? Could…
STAT+: Democrats win power to push back on Trump’s health care moves
Democrats win Senate control, and with it the power to push back on Trump’s health care moves.
STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test
Servier reports a surprise setback for a drug being tested for a form of muscular dystrophy that lacks treatment.
STAT+: Amid Mass General Brigham layoffs, CEO pens vague letter, stirring staff anxiety
A cryptic email sent to Mass General Brigham employees by the health system's CEO is stirring staff anxiety less than two weeks after a round of layoffs.
Give us all a share of Rolls-Royce’s profits | Brief letters
Government should invest, not subsidise | Size matters | ‘Ferritin face’ | Train announcements | Reform UK’s newspaperRather than give Rolls-Royce a £1.25bn subsidy to develop the…
‘The nipple touch of doom’: what is sad nipple syndrome and what causes it?
People everywhere are searching for the reason behind their sudden bursts of anguish or homesicknessWomen: was your autoimmune condition misdiagnosed?Some say it feels like a sudd…
STAT+: Who will get the first psychedelic approved?
The biotech Compass Pathways has been seen as one of the frontrunners in the race to get the first psychedelic drug approved. But it could be a tight race, with a non-profit…
STAT+: What do the midterms mean for health care?
STAT unpacks what the midterms mean for health policy, MAHA, and health insurance.
STAT+: FDA, CMS look to collaborate with states on health AI
In this edition of STAT Health Tech: Federal officials look to work with states on regulating AI, protecting doctors from AI liability, and more.
STAT+: Pharmalittle: We’re reading about a generic HIV prevention shot, Lonza buying U.S. facilities, and more
The FDA gave tentative approval to Dr. Reddy’s Laboratories to make a generic version of a groundbreaking HIV prevention medicine
Child dies of measles in New York’s first such death in 30 years
A child in rural northern New York has died after contracting measles, marking the state's first death from the disease in 30 years.
First U.S. bird flu death of the year after cattle exposure
A person in Washington state has died from complications of the bird flu, the AP reported yesterday. It’s the first such death this year in the U.S., and the third…
‘Three-parent IVF’ was supposed to prevent mitochondrial disease. Studies are raising doubts
Scientists and ethicists are rethinking the potential risks and benefits of a technology to prevent babies from inheriting rare mitochondrial diseases.
Opinion: How meditation helped me become a better doctor overnight
“The inner work of meditation and self-inquiry can support the outer work of patient care,” writes a physician.